Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06841198 · ClinicalTrials.gov registry record · NA
Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury
A NA study of Spinal Cord Injuries (SCI) and Cardiovascular, sponsored by Kessler Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT06841198: Recruiting NA study of Spinal Cord Injuries (SCI) and Cardiovascular, sponsored by Kessler Foundation.
NCT06841198 is a NA study of Spinal Cord Injuries (SCI) and Cardiovascular that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 5 participants, below the 67-participant average among 9 other Spinal Cord Injuries (SCI) trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06841198, a NA study of Spinal Cord Injuries (SCI) and Cardiovascular, is actively recruiting participants, sponsored by Kessler Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to explore how cardiovascular function changes in the first year after a spinal cord injury, and to see how different treatments, like spinal stimulation through the skin (transcutaneous spinal stimulation), affect blood pressure. The main questions are: How does stimulation affect blood pressure over the year? What is the level of cardiovascular activation throughout the year? The study will start during the inpatient stay at the Kessler Institute for Rehabilitation and continue after discharge as an outpatient, totaling about 20-29 sessions over the year.
Primary Outcome
Spatiotemporal mapping sessions involving stimulation of various spinal segments, utilizing different parameters (e.g., frequency, waveform). A BP response in a mapping session will be defined by a significant increase in SBP of at least 20 mmHg with stimulation compared to baseline SBP (without stimulation)
Conditions Studied
Interventions
- DEVICE spinal cord transcutaneous stimulation
Study Locations (1)
New Jersey
- Kessler Foundation - West Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT06841198 shows while recruiting
NCT06841198 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 67-participant average among 9 other Spinal Cord Injuries (SCI) trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with Spinal Cord Injuries (SCI) appearing as the primary indexed condition, and to 1 intervention - of which spinal cord transcutaneous stimulation is the first listed.
NCT06841198 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06841198 about?
NCT06841198 is a clinical study titled "Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury". The study aims to explore how cardiovascular function changes in the first year after a spinal cord injury, and to see how different treatments, like spinal stimulation through the skin (transcutaneous spinal stimulation), affect blood pressure. The main questions are: How does stimulation affect ...
What is the current status of trial NCT06841198?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-04-01. Estimated completion is 2026-11.
What conditions does trial NCT06841198 study?
This clinical trial studies the following conditions: Spinal Cord Injuries (SCI), Cardiovascular, Orthostatic Hypotension, Dysautonomic, Transcutaneous Spinal Stimulation.
What interventions are being tested in trial NCT06841198?
The interventions under investigation include: spinal cord transcutaneous stimulation (DEVICE).
Who is sponsoring clinical trial NCT06841198?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06841198 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries (SCI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06841198's enrollment target sits among peer trials
5 10th of 9 the lowest of 9 other Spinal Cord Injuries (SCI) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries (SCI) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Self-balancing Personal Exoskeleton for SCI
RECRUITING · NA
-
Hypoxia Pathways for Early Recovery After Spinal Cord Injury
RECRUITING · NA
-
Self-balancing Personal Exoskeleton for SCI (Site 2)
RECRUITING · NA
-
Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing
RECRUITING · NA
-
Health Information for Persons With Spinal Cord Injury
RECRUITING · NA
-
Virtual Peer Coaching in Manual Wheelchair Skills
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI